CVS Group Continues Buyback with Cancellation of Further 16,337 Shares

The latest update is out from CVS Group plc ( (GB:CVSG) ).

CVS Group plc has repurchased 16,337 of its own ordinary shares on 5 January 2026 as part of the share buyback programme launched in October 2025, at prices between 1,262p and 1,282p per share and a volume-weighted average of 1,273.40p. The company intends to cancel all of these shares, reducing the total number of shares in issue to 70,675,238 and leaving no treasury shares, bringing total repurchases under the programme to 1,065,545 shares; this buyback and cancellation marginally increases remaining shareholders’ proportional ownership and clarifies the voting rights base for regulatory disclosure purposes.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1320.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is a UK-based veterinary services company operating a network of veterinary practices and related businesses. The Group provides clinical veterinary care and associated services, with its shares listed on the London Stock Exchange and subject to UK financial regulation, including the FCA’s Disclosure and Transparency Rules.

Average Trading Volume: 433,706

Technical Sentiment Signal: Buy

Current Market Cap: £900.8M

For detailed information about CVSG stock, go to TipRanks’ Stock Analysis page.